The "Global Bioreactors Market (2022-2027) by Product Type, Cell, Molecule, Usage, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Nov 4, 2022--
The Global Bioreactors Market is estimated to be USD 1.66 Bn in 2022 and is expected to reach USD 2.68 Bn by 2027, growing at a CAGR of 10.06%.
The Global Bioreactors Market is segmented based on Product Type, Cell, Molecule, Usage, End-User, and Geography.
By Product Type, the market is classified into Single-use and Reusable.
By Cell, the market is classified into Mammalian Cells, Bacterial Cells, Yeast Cells, and Others.
By Molecule, the market is classified into Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others.
By Usage, the market is classified into Developmental, Pre-Clinical & Clinical, and Commercial Production.
By End-User, the market is classified into R&D Organizations, Biopharmaceutical Manufacturers, and Contract Manufacturing Organizations (CMO).
By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Rapid Growth of the Biopharmaceuticals and Biologics Industry
Technology Advancements in Bioreactors
Adoption of Single-Use Bioreactors (Subs) and Hybrid Bioreactors
Increasing Demand for Personalized Medicine
Low Capacity of Single-Use Bioreactor or Disposable Bioreactor
Concerns Regarding Extrables and Leachables
High Market Potential in Emerging Economies
Rising Demand for Personalized Medicine
Stringent Regulatory Framework
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
A complete analysis of the market, including the parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
6 Global Bioreactors Market, By Product Type
7 Global Bioreactors Market, By Cell
8 Global Bioreactors Market, By Molecule
9 Global Bioreactors Market, By Usage
10 Global Bioreactors Market, By End-User
11 Americas' Bioreactors Market
12 Europe's Bioreactors Market
13 Middle East and Africa's Bioreactors Market
14 APAC's Bioreactors Market
3D Biotek LLC
Applikon Biotechnology BV
BBI-Biotech GmbH
Bioengineering AG
Broadley-James Corp.
Cell Culture Company
Cytiva
Eppendorf AG
GEA Group AG
Infors AG
Merck KGaA
Pall Corp.
Pierre Guerin SAS
Praj Hipurity Systems Ltd.
Sartorius AG
Solaris Biotechnology S.r.l
Solida Biotech GmBH
Thermo Fisher Scientific Inc.
ZETA Holding GmbH
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE OTHER SCIENCE PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/04/2022 12:59 PM/DISC: 11/04/2022 12:59 PM
http://www.businesswire.com/news/home/20221104005543/en